SCHEMBL16985242

SCHEMBL16985242

CS(=O)(=O)c1cc2cnccc2o1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.39
CA2 P00918 8/20 0.39
CCR2 P41597 3/20 0.36
NAMPT P43490 2/20 0.36
HDAC3 O15379 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
NCOR2 Q9Y618 1/20 0.34
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
AKR1B1 P15121 1/20 0.33
RAPGEF4 Q8WZA2 1/20 0.33
CYP2C9 P11712 1/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
PIK3CG P48736 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18233455 0.86 NAMPT (0.39) CA2NAMPTCYP2C9
SCHEMBL10860405 0.83 CA2 (0.39) MKNK1CA2CCR2NAMPTHDAC3
SCHEMBL10558035 0.83 CA2 (0.59) CA2NAMPT
SCHEMBL16985241 0.74 CA2 (0.67) CA2CCR2POLBAKR1B1
SCHEMBL18233486 0.73 ADAMTS4 (0.40) NAMPTHDAC3HDAC1HDAC2NCOR2
Hydrochloric Acid SCHEMBL18223852 0.72 ADAMTS4 (0.39) NAMPTHDAC3HDAC1HDAC2NCOR2
SCHEMBL126266 0.72 MAPT (0.51) MKNK1HDAC3HDAC1HDAC2NCOR2
SCHEMBL18233494 0.72 NAMPT (0.35) MKNK1NAMPTHDAC3HDAC1HDAC2
Hydrochloric Acid SCHEMBL18223643 0.71 NAMPT (0.34) MKNK1NAMPTHDAC3HDAC1HDAC2
SCHEMBL16985243 0.70 CA2 (0.51) MKNK1CA2CCR2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10626112-B2 Heterocyclic sulfonamide derivative and medicine comprising same EA PHARMA CO., LTD. (JP) 2020-04-21 US disclosed
US-20180162844-A1 CYCLOPROPANE DERIVATIVE AND DRUG CONTAINING SAME EA PHARMA CO., LTD. (JP) 2018-06-14 US disclosed
US-20180162844-A1 CYCLOPROPANE DERIVATIVE AND DRUG CONTAINING SAME EA PHARMA CO., LTD. (JP) 2018-06-14 US disclosed
EP-3330266-A1 CYCLOPROPANE DERIVATIVE AND DRUG CONTAINING SAME EA PHARMA CO., LTD. (JP) 2018-06-06 EP disclosed
US-20160332999-A1 HETEROCYCLIC SULFONAMIDE DERIVATIVE AND MEDICINE COMPRISING SAME EA PHARMA CO., LTD. (JP) 2016-11-17 US disclosed
US-20160332999-A1 HETEROCYCLIC SULFONAMIDE DERIVATIVE AND MEDICINE COMPRISING SAME EA PHARMA CO., LTD. (JP) 2016-11-17 US disclosed
WO-2015115507-A1 HETEROCYCLIC SULFONAMIDE DERIVATIVE AND MEDICINE COMPRISING SAME 味の素株式会社 2015-08-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160332999-A1 HETEROCYCLIC SULFONAMIDE DERIVATIVE AND MEDICINE COMPRISING SAME TRPA1, TRPV1, TRPV2 MKNK1 3076/4885CA2 210/4885CCR2 615/4885
US-10626112-B2 Heterocyclic sulfonamide derivative and medicine comprising same TRPA1, TRPV1, TRPV2 MKNK1 3076/4885CA2 210/4885CCR2 615/4885
US-20180162844-A1 CYCLOPROPANE DERIVATIVE AND DRUG CONTAINING SAME TRPA1, TRPV1, TRPV2 MKNK1 3348/4885CA2 834/4885CCR2 444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.